Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...
Exclusive: DNA test would mean patients could be offered most effective treatment first, boosting their chances of beating the disease ...
Clinicians treating patients with estrogen receptor (ER)-positive/HER2-negative metastatic breast cancer are navigating ...
When most people think about cancer, they think of bad luck, lifestyle choices, or something that “just happens.” Very few ...
1Department of Pathology, Qilu Hospital, Shandong University, Jinan, China. 2Department of Pathology, Peking University People’s Hospital, Beijing, China. Search for other works by this author on: ...
Reno, Nevada (UroToday.com) -- Positive high-level results from the CAPItello-281 Phase III trial showed that AstraZeneca’s Truqap (capivasertib) in combination with abiraterone and androgen ...
In this study, we asked whether low PTEN expression in metastatic hormone-sensitive prostate cancer (mHSPC) is associated with worse clinical outcomes and whether these tumors display a distinct ...
FDA approvals of Pluvicto and darolutamide offer new treatment options for metastatic prostate cancer, improving progression-free survival and quality of life. Genomic testing and advanced imaging ...
America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments. Credit... Supported by By Jonathan Mahler Rachael Sirianni first ...
The share price of Patterson-UTI Energy, Inc. (NASDAQ:PTEN) fell by 9.31% between July 11 and July 18, 2025, putting it among the Energy Stocks that Lost the Most This Week. Patterson-UTI Energy, Inc.
Breast cancer. Colon cancer. An enlarged thyroid gland. A family history of tumors and cancers as well. It wasn’t until the woman developed an annoying case of dry mouth that doctors put it all ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VCYT--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that eight abstracts ...